Rationale and design of the comParIson Of sacubitril/valsartaN versus Enalapril on Effect on nt-pRo-bnp in patients stabilized from an acute Heart Failure episode (PIONEER-HF) trial

Conclusion The PIONEER-HF trial will inform clinical practice by providing evidence on the safety, tolerability and efficacy of in-hospital initiation of sacubitril/valsartan among patients who have been stabilized following an admission for acute decompensated HF with a reduced EF.
Source: American Heart Journal - Category: Cardiology Source Type: research